Selectin inhibitors and their proposed role in ischemia and reperfusion

Journal of Investigative Surgery

Volumn 20, Issue 2, 2007, Pages 71-85

  Calvey, Colleen R ^a   Toledo Pereyra, Luis H ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Borgess Research Institute   (United States)

Author keywords

Ischemia; Reperfusion; Selectin inhibitors

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA SQAG9; BIMOSIAMOSE; CELL ADHESION MOLECULE; CY 1503; CYCLOSPORIN A; CYLEXIN; EFOMYCINE M; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; L SELECTIN; MOCARRHAGIN; MONOCLONAL ANTIBODY; NITRIC OXIDE; OC 229 648; P SELECTIN GLYCOPROTEIN LIGAND 1 INHIBITOR; PADGEM PROTEIN; PLACEBO; QUINIC ACID DERIVATIVE; RAPAMYCIN; RECOMBINANT P SELECTIN GLYCOPROTEIN LIGAND 1; SELECTIN; SELECTIN ANTAGONIST; SELECTIN MONOCLONAL ANTIBODY; TB 1269; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; ATHEROSCLEROSIS; CELL ADHESION; CLINICAL TRIAL; CONTINUOUS INFUSION; DELAYED GRAFT FUNCTION; DELAYED HYPERSENSITIVITY; DRUG ANTAGONISM; DRUG ANTIGENICITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG SAFETY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HEMORRHAGIC SHOCK; HUMAN; ISCHEMIA; KIDNEY ISCHEMIA; LEUKOCYTE ACTIVATION; LIVER ISCHEMIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PSORIASIS; REPERFUSION INJURY; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; TISSUE INJURY;

ANIMALS; CELL ADHESION; HUMANS; ISCHEMIA; REPERFUSION INJURY; SELECTINS; SHOCK, HEMORRHAGIC;

EID: 34247588115     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.1080/08941930701250212     Document Type: Review

References (33)

1. Kogan, T. P., Dupré B. Bui H. McAbee K. L. Kassir J. M. Scott I. L. Vanderslice P. Beck P. J. Dixon R. A.F. (1998) Novel synthetic inhibitors of selectin-mediated cell adhesion: Synthesis of 1,6-bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)phenyl] hexane (TBC1269). J Med Chem., 41, pp. 1099-1111.
2. Davenpeck, K. L., Berens, K. L., Dixon, R AF, Dupŕ B. and Bochner, B. S. (2000) Inhibition of adhesion of human neutrophils and esoinophils to P-selectin by the sialyl Lewisx antagonist TBC1269: Preferential activity against neutrophil adhesion in vitro. J Allergy Clin Immunol., 105, pp. 769-775.
3. Harlan, J. M. and Liu, D. Y. (1992) Adhesion: Its Role in Inflammatory Disease., pp. 19-43. WH Freeman, New York
4. Ley, K. (2003) The role of selectins in inflammation and disease. Trends Mol Med, 9, pp. 263-268.
5. Lefer, D. J. (2000) Pharmacology of selectin inhibitors in ischemia/ reperfusion states. Annu Rev Pharmacol Toxicol., 40, pp. 283-294.
6. Martinez-Mier, G., Toledo-Pereyra, L. H. and Ward, P. A. (2001) Adhesion molecules and hemorrhagic shock. J Trauma., 51, pp. 408-415.
7. Kaila, N. and Thomas, B. E. (2002) IV. Design and synthesis of sialyl Lewisx mimics as E- and P-selectin inhibitors. Med Res Rev., 22, pp. 566-601.
8. Lutters, B CH, Leeuwenburgh, M. A., Appeldoorn, C CM, Molenaar, T JM, Van Berkel, T JC and Biessen, E AL (2004) Blocking endothelial adhesion molecules: A potential therapeutic strategy to combat atherogenesis. Curr Opin Lipidol, 15, pp. 545-552.
9. Boehncke, W. H. and Schön, M. P. (2003) Interfering with leukocyte rolling - A promising therapeutic approach in inflammatory skin disorders. Trends Pharm Sci., 24, pp. 49-52.
10. Toledo-Pereyra, L. H., Toledo, A. H., Walsh, J. and Lopez-Neblina, F. (2004) Molecular signaling pathways in ischemia/reperfusion. Exp Clin Transpl., 2, pp. 174-177.
11. Winn, R. K., Paulson, J. C. and Harlan, J. M. (1994) A monoclonal antibody to P-selectin ameliorates injury associated with hemorrhagic shock in rabbits. Am J Physiol., 267, p. H2391.
12. Lefer, A. M., Campbell, B. and Shin, Y-K (1998) Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion. J Mol Cell Cardiol., 30, pp. 2561-2566.
13. Dulkanchainun, T. S., Goss, J. A., Imagawa, D. K., Shaw, G. D., Anselmo, D. M., Kaldas, F., Wang, T., Zhao, D., Busuttil, A. A., Kato, H., Murray, N GB, Kupiec-Weglinski, J. W. and Busuttil, R. W. (1998) Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg., 227, pp. 832-840.
14. Hayward, R., Campbell, B., Shin, Y. K., Scalia, R. and Lefer, A. M. (1998) Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Card Res., 41, pp. 65-76.
15. Slee, D. H., Romano, J. Y., Nguyen, T. N., John, J. K., Raheja, N. K., Axe, F. U., Jones, T. K. and Ripka, W. C. (2001) Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with anitiinflammatory activity. J Med Chem., 44, pp. 2094-2107.
16. Hicks, A ER, Abbitt, K. B., Dodd, P., Ridger, V. C., Hellewell, P. G. and Norman, K. E. (2005) The anti-inflammatory effects of a selectin ligand mimetic, TBC-1269, are not a result of competitive inhibition of leukocyte rolling in vivo. J Leukocyte Biol, 77, pp. 59-66.
17. Ramos-Kelly, J. R., Toledo-Pereyra, L. H., Jordan, J. A., Rivera-Chavez, F. A., Dixon, R AF and Ward, P. A. (1999) Upregulation of lung chemokines associated with hemorrhage is reversed with a small molecule multiple selectin inhibitor. J Am Coll Surg., 189, pp. 546-553.
18. Nemoto, T., Burne, M. J., Daniels, F., O'Donnell, M. P., Crosson, J., Berens, K., Issekutz, A., Kasiske, B. L., Keane, W. F. and Raab, H. (2001) Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int., 60, pp. 2205-2214.
19. Palma-Vargas, J. M., Toledo-Pereyra, L. H., Dean, R. E., Harkema, J. M., Dixon, R AF and Kogan, T. P. (1997) Small-molecule selectin inhibitor protects against liver inflammatory response after ischemia and reperfusion. Am Coll Surgeons., 185, pp. 379-387.
20. Martinez-Mier, G., Toledo-Pereyra, L. H. and Ward, P. A. (2000) Adhesion molecules in liver ischemia and reperfusion. J Surg Res., 94, pp. 185-194.
21. Toledo-Pereyra, L. H., Lopez-Neblina, F., Reuben, J. S., Toledo, A. H. and Ward, P. A. (2004) Selectin inhibition modulates Akt/MAPK signaling and chemokine expression after liver ischemia-reperfusion. J Invest Sur., 17, pp. 303-313.
22. Ramos-Kelly, J. R., Toledo-Pereyra, L. H., Jordan, J., Rivera-Chavez, F., Rohs, T., Holevar, M., Dixon, R AF, Yun, E. and Ward, P. A. (2000) Multiple selectin blockade with a small molecule inhibitor downregulates liver chemokine expression and neutrophil infiltration after hemorrhagic shock. J Trauma, 49, pp. 92-100.
23. Langer, R., Wang, M., Stepkowski, S. M., Hancock, W. W., Han, R., Feng, L., Kirken, R. A., Berens, K. L., Duprö, B., Podder, H., Dixon, R AF and Kahan, B. D. (2004) Selectin inhibitor Bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines. J Am Soc Nephrol., 15, pp. 2893-2901.
24. Jayle, C., Milinkevitch, S., Favreau, F., Doucet, C., Richer, J. P., Deretz, S., Mauco, G., Raab, H. and Hauet, T. (2006) Protective role of selectin ligand inhibition in a large animal model of kidney ischemia-reperfusion injury. Kidney Int., 69, pp. 1749-1755.
25. Onai, Y., Suzuki, J., Nishiwaki, Y., Gotoh, R., Berens, K., Dixon, R., Yoshida, M., Ito, H. and Isobe, M. (2003) Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischemia/ reperfusion injury. Eur J Pharmacol., 481, pp. 217-225.
26. Ulbrich, H., Eriksson, E. E. and Lindbom, L. (2003) Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharm Sci., 24, pp. 640-647.
27. Romano, S. J. (2005) Selectin antagonists. Treat Respir Med., 4, pp. 85-90.
28. κB and AP-1 signaling after liver ischemia/ reperfusion. J Invest Surg., 19, pp. 313-322.
29. Schön, M. P., Krahn, T., Schön, M., Rodriguez, M-L, Antonicek, H., Schultz, J. E., Ludwig, R. J., Zollner, T. M., Bischoff, E., Bremm, K-D, Schramm, M., Henninger, K., Kaufmann, R., Gollnick, H PM, Parker, C. M. and Boehncke, W-H (2002) Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat Med., 8, pp. 366-372.
30. Wienrich, B. G., Krahn, T., Scḧn, M., Rodriguez, M. L., Kramer, B., Busemann, M., Boehncke, W. H. and Schön, M. P. (2006) Structure-function relation of efomycines, a family of small-molecule inhibitors of selectin functions. J Invest Dermatol, 126, pp. 882-889.
31. Kaila, N., Somers, W. S., Thomas, B. E., Thakker, P., Janz, K., DeBernardo, S., Tam, S., Moore, W. J., Yang, R., Wrona, W., Bedard, P. W., Crommie, D., Keith, J. C., Tsao, D HH, Alvarez, J. C., Marchese, E., Patton, J. T., Magnani, J. L. and Camphausen, R. T. (2005) Quinic acid derivatives as sialyl Lewisx-mimicking selectin inhibitors: Design, synthesis, and crystal structure in complex with E-selectin. J Med Chem., 48, pp. 4346-4357.
32. Shima, H., Tsuruma, T., Sahara, H., Takenouchi, M., Takahashi, N., Iwayama, Y., Yagihashi, A., Watanabe, N., Sato, N. and Hirata, K. (2005) Treatment with β-SQAG9 prevents rat hepatic ischemia-reperfusion injury. Transpl Proc., 37, pp. 417-421.
33. Cahmoun, F., Burne, M., O'Donnell, M. and Rabb, H. (2000) Pathophysiologic role of seletins and their ligands in ischemia reperfusion injury. Front Biosci., 5, pp. e103-e109.